@article{1fc9fd06e0714d85807ea9377431d5eb,
title = "Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)",
keywords = "Clinical Trials, Combination, Drug Therapy, Immunotherapy, Phase II as Topic, Sarcoma",
author = "Wagner, {Michael J.} and Megan Othus and Patel, {Sandip P.} and Chris Ryan and Ashish Sangal and Benjamin Powers and Budd, {G. Thomas} and Victor, {Adrienne I.} and Hsueh, {Chung Tsen} and Rashmi Chugh and Suresh Nair and Leu, {Kirsten M.} and Mark Agulnik and Elad Sharon and Edward Mayerson and Melissa Plets and Charles Blanke and Howard Streicher and Chae, {Young Kwang} and Razelle Kurzrock",
note = "Publisher Copyright: {\textcopyright} 2021 BMJ Publishing Group. All rights reserved.",
year = "2021",
month = aug,
day = "11",
doi = "10.1136/jitc-2021-002990",
language = "English",
volume = "9",
journal = "Journal for immunotherapy of cancer",
issn = "2051-1426",
number = "8",
}